Sargent Investment Group’s Antares Pharma, Inc. ATRS Stock Holding History

Sargent Investment Group’s Portfolio ATRS Stock Details ATRS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-200,000	Closed	-$50K	–	206
2022 Q1	$50K	Buy	+200,000	New	+$726K	0.01%	187
2021 Q4	–	Sell	-100,000	Closed	-$15K	–	203
2021 Q3	$15K	Buy	+100,000	New	+$404K	﹤0.01%	193
2021 Q2	–	Sell	-200,000	Closed	-$18K	–	220
2021 Q1	$18K	Hold	200,000	–	–	﹤0.01%	195
2020 Q4	$183K	Buy	200,000 +150,000	+300%	+$485K	0.06%	170
2020 Q3	$26K	Buy	+50,000	New	+$138K	0.01%	162

Other funds holding ATRS

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Sargent Investment Group's ATRS Position: Q2 2022 in Review

Sargent Investment Group sold out of Antares Pharma, Inc. (ATRS) in Q2 2022, closing a stake of 3,663,275 shares — an estimated $15M sold.

Sargent Investment Group first reported a position in ATRS in Q4 2018 and held it in 14 quarters. The position peaked at $19.2M in Q4 2019. 1 fund tracked by Wall St. Rank holds ATRS as of Q2 2022.

Sargent Investment Group reported no remaining Antares Pharma, Inc. position as of Q2 2022 after selling out during the quarter.
Sargent Investment Group sold 3,663,275 Antares Pharma, Inc. shares in Q2 2022, an estimated $15M.
Sargent Investment Group first reported a position in Antares Pharma, Inc. in Q4 2018 and held it in 14 quarters.
Sargent Investment Group's Antares Pharma, Inc. position peaked at $19.2M in Q4 2019.
1 fund tracked by Wall St. Rank held Antares Pharma, Inc. as of Q2 2022.

Based on Sargent Investment Group's 13F filing for Q2 2022, filed 26 Jul 2022.